Takeda Pharmaceutical Co Ltd
NYSE:TAK
Takeda Pharmaceutical Co Ltd
NYSE:TAK
Price:
17.91
USD
-0.83%
Market Closed
Market Cap:
$56.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Takeda Pharmaceutical Co Ltd
NYSE:TAK
|
JP |
|
Uday Jewellery Industries Ltd
BSE:539518
|
IN |
|
Ardent Health Partners Inc
NYSE:ARDT
|
US |
Multiples-Based Value
The Multiples-Based Value of one
TAK
stock under the Base Case scenario is
19.94
USD.
Compared to the current market price of 17.91 USD,
Takeda Pharmaceutical Co Ltd
is
Undervalued by 10%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TAK
Multiples-Based Value
Base Case
19.94
USD
Undervaluation 10%
Multiples Across Competitors
TAK Competitors Multiples
Takeda Pharmaceutical Co Ltd Competitors
Takeda Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
|
Takeda Pharmaceutical Co Ltd
NYSE:TAK
|
9.2T USD | 2.1 | 81.7 | 10.4 | 26.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.7 | 40.2 | 27.2 | 29 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.6 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 9.8 | 7.3 | 8.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.4 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
